CIBC Bancorp USA’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
CIBC Bancorp USA's WST Position: Q3 2026 in Review
CIBC Bancorp USA reduced its West Pharmaceutical (WST) stake by 17% in Q3 2026, selling an estimated $1.26M and leaving 17,666 shares worth $6.55M. The position accounts for 0.01% of the portfolio, ranked #664.
CIBC Bancorp USA first reported a position in WST in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.62M in Q2 2026. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- CIBC Bancorp USA held 17,666 shares of West Pharmaceutical worth $6.55M as of Q3 2026.
- CIBC Bancorp USA sold 3,559 West Pharmaceutical shares in Q3 2026, an estimated $1.26M.
- West Pharmaceutical made up 0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #664 holding.
- CIBC Bancorp USA first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
- CIBC Bancorp USA's West Pharmaceutical position peaked at $7.62M in Q2 2026.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.